Norditropine simplex ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 238 | Vitamin D-resistant rickets | 1 |
238. Vitamin D-resistant rickets
Clinical trials : 28 / Drugs : 20 - (DrugBank : 9) / Drug target genes : 3 - Drug target pathways : 16
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02720770 (ClinicalTrials.gov) | January 2006 | 15/3/2016 | Growth Hormone Treatment in Children With Hypophosphatemic Rickets | Proposition Pour un Traitement Par Hormone de Croissance Des Enfants Atteints de Rachitisme Hypophosphatemique Familial | X Linked Hypophosphatemic Rickets | Drug: norditropine simplex | Bicetre Hospital | NULL | Completed | 3 Years | 14 Years | Both | 19 | Phase 1/Phase 2 | NULL |